APOTHEEK HECHTEL
ActiveThe computed 12-month bankruptcy probability of APOTHEEK HECHTEL is 1.5% (moderate). The 2025 annual accounts show equity of €619k and a net result of €145k. Equity is growing by ~24.3% per year across the filed fiscal years. Its solvency ranks better than 86% of 10345 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
85
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability91▲+7
Solvency100▲+5
Growth52=
Track record94
Bankruptcy probability, 12 months
1.5%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €50k at 30 days acceptable
Liquidity ample (current ratio 3.86 against 2.73 in 2024; short-term debt: 23.2% and cash: 44.4% of total assets), and 23.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
76.6%
Return on assets
17.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
23 d early
2024
37 d early
2023
27 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€619k▲ 30.6%
2024 · €474k
2023: €388k
2024: €474k
2023 → 2025
Total assets
€808k▲ 18.6%
2024 · €682k
2023: €1.00M
2024: €682k
2023 → 2025
Net result
€145k▲ 69.3%
2024 · €86k
2023: €385k
2024: €86k
2023 → 2025
Working capital
€535k▲ 50.2%
2024 · €356k
2023: €303k
2024: €356k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€388k-€474k▲ 22.1%€619k▲ 30.6%
Operating result€522k-€111k▼ 78.8%€192k▲ 72.8%
Net result€385k-€86k▼ 77.8%€145k▲ 69.3%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 73% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €808k
Fixed assets
€86k▼ 28.1%
Current assets
€723k▲ 28.4%
Equity and liabilities €808k
Equity
€619k▲ 30.6%
Debt
€189k▼ 8.9%
The debt ratio falls from 30.5% to 23.4%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€221k▲
2024 · €139k
Cash flow
€174k▲
2024 · €114k
Solvency
76.6%▲
2024 · 69.5%
Current ratio
3.86▲
2024 · 2.73
Quick ratio
2.67▲
2024 · 1.70
Debt / equity
0.31▼
2024 · 0.44
ROE
23.4%▲
2024 · 18.1%
ROA
17.9%▲
2024 · 12.6%
Interest coverage
74.23▲
2024 · 51.39
Debt
€189k▼
2024 · €208k
Debt ≤ 1 year
€187k▼
2024 · €206k
Income taxes
€44k▲
2024 · €23k
Staff costs
€95k=
2024 · €95k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€682k€808k▲
Fixed assets21/28€119k€86k▼
Intangible fixed assets21-€0
Tangible fixed assets22/27€119k€86k▼
Land and buildings22€8k€7k▼
Plant, machinery and equipment23€46k€32k▼
Furniture and vehicles24€64k€47k▼
Current assets29/58€563k€723k▲
Stocks and contracts in progress3€212k€222k▲
Stocks30/36€212k€222k▲
Amounts receivable within one year40/41€141k€137k▼
Trade receivables40€139k€137k▼
Other amounts receivable41€3k€0▼
Current investments50/53€0-
Cash at bank and in hand54/58€205k€359k▲
Deferred charges and accrued income490/1€3k€5k▲
Equity and liabilities
Total equity and liabilities10/49€682k€808k▲
Equity10/15€474k€619k▲
Contributions10/11€3k€3k=
Reserves13€471k€616k▲
Distributable reserves133€471k€616k▲
Amounts payable17/49€208k€189k▼
Amounts payable within one year42/48€206k€187k▼
Trade debts44€171k€124k▼
Suppliers440/4€171k€124k▼
Taxes, remuneration and social security45€35k€63k▲
Taxes450/3€23k€51k▲
Remuneration and social security454/9€12k€12k▲
Other amounts payable47/48€422€490▲
Accrued charges and deferred income492/3€1k€2k▲
Income statement
Code20242025
Remuneration, social security and pensions62€95k€95k=
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€28k€29k▲
Other operating charges640/8€1k€7k▲
Non-recurring operating charges66A€234€826▲
Gross operating margin9900€236k€323k▲
Operating profit (loss)9901€111k€192k▲
Financial income75/76B€912€130▼
Recurring financial income75€912€130▼
Financial charges65/66B€3k€3k▲
Recurring financial charges65€3k€3k▲
Profit (loss) for the period before taxes9903€109k€189k▲
Income taxes67/77€23k€44k▲
Profit (loss) for the period9904€86k€145k▲
Profit (loss) for the period to be appropriated9905€86k€145k▲
Appropriation of the result
Profit (loss) to be appropriated9906€86k€145k▲
Transfer to equity691/2€86k€145k▲
To other reserves6921€86k€145k▲
Social balance
Average headcount (FTE)90870.01.5▲
The notes to these accounts (16 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
08-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Equity above €500kEq €619k ▲30.6%
3 profitable years in a row build equity to €619k.
24-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Weakest financial yearnet €86k ▼77.8%
Net result drops to €86k, the lowest in the series; recovery starts the following year.
04-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hechtel-Eksel · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Tussenstraat 73940 Hechtel-EkselGround area
997 m²
Building footprint
197 m²
Volume, LiDAR
1,047 m³
Parcel 72013C0418/00A000, Flanders · tallest building 7.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK HECHTEL
since 20222.336.367.338
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 72013C0418/00A000 | Flanders | 997 m² | 1 · 197 m² | 7.4 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
MOERMAN ANN
BE 0808.468.175
Knokke-Heist · Eq €619k
SANIMED
BE 0448.804.548
Oudenburg · Eq €619k
Pharma Invest Devos
BE 0899.883.252
Halle · Eq €618k
MENDELJEV
BE 0830.138.866
Beernem · Eq €620k
APOTHEKER STEVEN VRIJDAG
BE 0817.319.624
Dendermonde · Eq €618k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,273 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-09-2022
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
47120Other non-specialised retail sale
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
47910Retail trade
70100Activities of head offices
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.